You are here

  • Home
  • Archive
  • Volume 3, Issue 3
  • Survival analysis of HDR brachytherapy versus reoperation versus temozolomide alone: a retrospective cohort analysis of recurrent glioblastoma multiforme

Article info

Article menu

Download PDFPDF

XML
Oncology
Research
Survival analysis of HDR brachytherapy versus reoperation versus temozolomide alone: a retrospective cohort analysis of recurrent glioblastoma multiforme

Authors

  • Eleftherios Archavlis Department of Neurosurgery, Klinikum Offenbach, Akademisches Lehrkrankenhaus der Universität Frankfurt, Offenbach, Germany PubMed articlesGoogle scholar articles
  • Nikolaos Tselis Department of Radiotherapy and Interdisciplinary Oncology, Klinikum Offenbach, Akademisches Lehrkrankenhaus der Universität Frankfurt, Offenbach, Germany PubMed articlesGoogle scholar articles
  • Gerhard Birn Department of Neurosurgery, Klinikum Darmstadt, Akademisches Lehrkrankenhaus der Universität Frankfurt, Offenbach, Germany PubMed articlesGoogle scholar articles
  • Peter Ulrich Department of Neurosurgery, Klinikum Offenbach, Akademisches Lehrkrankenhaus der Universität Frankfurt, Offenbach, GermanyDepartment of Radiotherapy and Interdisciplinary Oncology, Klinikum Offenbach, Akademisches Lehrkrankenhaus der Universität Frankfurt, Offenbach, Germany PubMed articlesGoogle scholar articles
  • Dimos Baltas Department of Medical Physics and Engineering, Klinikum Offenbach, Akademisches Lehrkrankenhaus der Universität Frankfurt, Offenbach, Germany PubMed articlesGoogle scholar articles
  • Nikolaos Zamboglou Department of Radiotherapy and Interdisciplinary Oncology, Klinikum Offenbach, Akademisches Lehrkrankenhaus der Universität Frankfurt, Offenbach, Germany PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Eleftherios Archavlis; neurosurgery{at}t-online.de
View Full Text

Citation

Archavlis E, Tselis N, Birn G, et al
Survival analysis of HDR brachytherapy versus reoperation versus temozolomide alone: a retrospective cohort analysis of recurrent glioblastoma multiforme
BMJ Open 2013;3:e002262. doi: 10.1136/bmjopen-2012-002262

Publication history

  • Received October 24, 2012
  • Revised February 15, 2013
  • Accepted February 22, 2013
  • First published March 15, 2013.
Online issue publication 
October 26, 2017
Previous versions
Review history

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions this is an open-access article distributed under the terms of the creative commons attribution non-commercial license, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited, the use is non commercial and is otherwise in compliance with the license. see: http://creativecommons.org/licenses/by-nc/2.0/ and http://creativecommons.org/licenses/by-nc/2.0/legalcode.